Bristol Myers Squibb Taps Microsoft’s AI Detection Network for Speedy Lung Cancer Diagnosis

Bristol Myers Squibb is leveraging Microsoft’s AI-powered Precision Imaging Network to accelerate detection of non-small cell lung cancer. Used by more than 80% of US hospitals, the platform analyzes X-ray and CT images to identify hard-to-detect nodules, with an emphasis on improving diagnosis speed and expanding access in rural and underserved communities.